Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urogenital Neoplasms × palbociclib × Clear all

Sponsor

Conditions

Breast Neoplasms 54 Squamous Cell Carcinoma of Head and Neck 4 Sarcoma 4 Neoplasm Metastasis 4 Sarcoma, Ewing 3 Neoplasms 3 Medulloblastoma 3 Lymphoma, Non-Hodgkin 3 Glioma 3 Carcinoma, Non-Small-Cell Lung 3 Astrocytoma 3 Wilms Tumor 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Recurrence 2 Osteosarcoma 2 Oligodendroglioma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Lymphoma 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioblastoma 2 Ependymoma 2 Colonic Neoplasms 2 Xanthogranuloma, Juvenile 1 Triple Negative Breast Neoplasms 1 Testicular Neoplasms 1 Teratoma 1 Recurrent Squamous Cell Lung Carcinoma 1

Interventions

Sunitinib 2 Paclitaxel 2 valrubicin 1 temsirolimus 1 sipuleucel-T 1 luprolide acetate gel depot 1 ferumoxtran-10 1 abiraterone 1 abemaciclib 1 Suspensions 1 Surveys and Questionnaires 1 Standard of Care 1 Radiotherapy 1 Prednisone 1 Prednisolone 1 Powders 1 Pemetrexed 1 Neoadjuvant Therapy 1 National Cancer Institute (U.S.) 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Leuprolide 1 Fatty Acids, Omega-3 1 Educational Status 1 Docetaxel 1 Bevacizumab 1 Atorvastatin 1 Administration, Intravesical 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡